Online Program Home
  My Program

Abstract Details

Activity Number: 29 - Bayesian Methods and Applications in Clinical Trials (I)
Type: Contributed
Date/Time: Sunday, July 30, 2017 : 2:00 PM to 3:50 PM
Sponsor: Biopharmaceutical Section
Abstract #324646
Title: Borrowing Historical Information for Clinical Development - a Case Study
Author(s): Guochen Song* and Peng Sun and John Zhong and Jie Li and Baoguang Han and Stacy Lindborg
Companies: Biogen and Biogen and Biogen and Biogen and Biogen and Biogen
Keywords: Bayesian ; Survival ; borrowing historical information
Abstract:

Nusinersen is the first FDA approved treatment for spinal muscular atrophy (SMA). Infantile-onset SMA is a rare fatal disease. The phase III study of nusinersen was ended early based on a positive interim analysis and to allow patients to gain early access to treatment. As a consequence the second primary endpoint of the study, ventilation free survival, was not expected to be sufficiently powered in the final analysis. A covariate-adjusted Bayesian hierarchical piece-wise exponential model was used to borrow information from the phase II trial as well as from two observational natural history trials. In this presentation, we will report the results of the planned Bayesian analysis to demonstrate that borrowing historical information narrows the creditable interval of the hazard ratio.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2017 program

 
 
Copyright © American Statistical Association